美股A股
StockGist
Back
10-Q2026-05-05· deepseek-chat

JBTM · JBT Marel Corporation

0001628280-26-030756

SEC filing

Summary

JBT Marel delivered a strong operational turnaround in Q1 2026, with revenue up 9.6% and net income swinging from a $173M loss to $45M profit, driven by margin expansion and cost controls.

Key takeaways

Full analysis

Protein Solutions Drives Top-Line Growth

Revenue increased 9.6% to $936.0 million in the first quarter of 2026, compared to $854.1 million in the prior-year period. The growth was primarily driven by higher volume in both recurring and non-recurring revenue, reflecting continued commercial momentum from global poultry customers and healthy demand from meat and fruit and vegetable end markets. Orders remained strong, supporting the top-line expansion.

Margin Expansion Through Synergies and Cost Control

Profitability Recovery and Cash Flow Strength

Operating income swung to $68.0 million from a loss of $33.4 million in the prior-year period, reflecting higher gross profit and lower SG&A expenses. Net income was $45.0 million, compared to a net loss of $173.0 million, driven by margin enhancement efforts, lower non-recurring and transaction-related costs, and lower interest expense. Diluted earnings per share were $0.86, compared to a loss of $3.35 per share. Net cash provided by operating activities was $119.0 million, demonstrating strong cash generation.

Segment Performance: Protein vs. Prepared Food

While segment-level financials are not separately disclosed in the authoritative packet, the overall revenue growth was supported by strong demand in protein solutions, partially offset by challenges in prepared food and beverage end markets. The company's focus on synergies and cost controls benefited overall profitability.

Restructuring Progress and Outlook

The company continues to execute on its restructuring initiatives, including the realization of Marel synergies. The increase in Adjusted EBITDA was driven by increased volume and gross profit from synergies. Management commentary highlights that bottom-line performance was driven by lower non-recurring costs and margin enhancement. Forward-looking statements should not be regarded as guarantees of future performance.